Atomic — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Vilyavilyatx.com inJun 2024

Vilya designs novel macrocycles using AI and computational biology to create medicines that don't exist in nature.

AI & Machine LearningBiotechDeep Tech

David Baker(Founder)Patrick Salveson, PhD(Co-Founder, CTO)Adam Moyer, PhD(Co-Founder, VP of Molecular Design)David Baker, PhD(Nobel laureate, Co-Founder, Director, IPD UW, Prof. Biochemistry)Gaurav Bhardwaj, PhD(Co-Founder, UW, Asst. Prof. Medicinal Chemistry)Lance Stewart, PhD, MBA(Co-Founder, CSO & COO, IPD)

Co-investorsARCH Venture Partners Madrona Venture Group Menlo Ventures NVIDIA Altitude Ventures Management, Llc Alumni Ventures +10 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Neurawell Therapeutics, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.